Biblio
Export 1530 results:
Author [ Title
Filters: First Letter Of Last Name is K [Clear All Filters]
“Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 3, pp. 979-991, 2019.
, “Quantifying and Examining Reserve in Symptomatic Former National Football League Players.”, J Alzheimers Dis, vol. 85, no. 2, pp. 675-689, 2021.
, “Quantifying the Diagnostic Pathway for Patients with Cognitive Impairment: Real-World Data from Seven European and North American Countries.”, J Alzheimers Dis, vol. 62, no. 1, pp. 457-466, 2018.
, “Quantitative 3D Telomeric Imaging of Buccal Cells Reveals Alzheimer's Disease-Specific Signatures.”, J Alzheimers Dis, vol. 58, no. 1, pp. 139-145, 2017.
, “Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.”, J Alzheimers Dis, vol. 56, no. 2, pp. 743-761, 2017.
, “Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels are Related to Higher Regional Cerebral Blood Flow on Brain SPECT.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1189-1199, 2017.
, “Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 66, no. 2, pp. 639-652, 2018.
, “Quantitative Mass Spectrometric Assay of Whole and CNBr-Cleaved Amyloid-β Peptides in Human Brain.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1637-1645, 2020.
, “Quantitative Metabolomic Analysis of the Rat Hippocampus: Effects of Age and of the Development of Alzheimer's Disease-Like Pathology.”, J Alzheimers Dis, vol. 99, no. s2, pp. S327-S344, 2024.
, “Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging.”, J Alzheimers Dis, vol. 49, no. 3, pp. 723-32, 2016.
, “Quantitative PET and Histology of Brain Biopsy Reveal Lack of Selective Pittsburgh Compound-B Binding to Intracerebral Amyloidoma.”, J Alzheimers Dis, 2018.
, “Quantitative phosphoproteomic analyses of the inferior parietal lobule from three different pathological stages of Alzheimer's disease.”, J Alzheimers Dis, vol. 49, no. 1, pp. 45-62, 2016.
, “Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project.”, J Alzheimers Dis, vol. 96, no. 1, pp. 359-368, 2023.
, “A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Oral ELND005 (scyllo-Inositol) in Young Adults with Down Syndrome without Dementia.”, J Alzheimers Dis, vol. 58, no. 2, pp. 401-411, 2017.
, “Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity.”, J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
, “Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 815-824, 2018.
, “The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.”, J Alzheimers Dis, vol. 61, no. 2, pp. 803-814, 2018.
, “Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
, “Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. 3, pp. 899-910, 2018.
, “Recalibrating the Risk-Benefit Profiles of Lecanemab and Donanemab: Scales, Immunoreactivity, and Changes in Amyloid-β42.”, J Alzheimers Dis, vol. 99, no. 3, pp. 877-881, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Recent Increases in Hippocampal Tau Pathology in the Aging Japanese Population: The Hisayama Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 613-624, 2017.
, “Recent Increases in Hippocampal Tau Pathology in the Aging Japanese Population: The Hisayama Study.”, J Alzheimers Dis, vol. 55, no. 2, pp. 613-624, 2017.
, “Reduced Benefit of Memory Elaboration in Older Adults with Subjective Memory Decline.”, J Alzheimers Dis, vol. 47, no. 3, pp. 705-13, 2015.
,